Efficacy Assessment of Radiotherapy Alone Versus Combined Surgery and Radiotherapy for Ipsilateral Supraclavicular Lymph Node Metastasis in Breast Cancer: A Retrospective Study with Eight-Year Follow-Up Utilizing Propensity Score Matching - Scorecard - MDSpire

Efficacy Assessment of Radiotherapy Alone Versus Combined Surgery and Radiotherapy for Ipsilateral Supraclavicular Lymph Node Metastasis in Breast Cancer: A Retrospective Study with Eight-Year Follow-Up Utilizing Propensity Score Matching

  • By

  • Chao Wei

  • Shuhua Zhou

  • Longyu Zhu

  • Jie Kong

  • Zimeng Gao

  • Danyang Wang

  • Deyou Kong

  • Andu Zhang

  • Shuo Pan

  • Kaiye Du

  • Dongxing Shen

  • Jun Zhang

  • Zhikun Liu

  • December 26, 2025

  • 0 min

Share

Clinical Scorecard: Efficacy Assessment of Radiotherapy Alone Versus Combined Surgery and Radiotherapy for Ipsilateral Supraclavicular Lymph Node Metastasis in Breast Cancer: A Retrospective Study with Eight-Year Follow-Up Utilizing Propensity Score Matching

At a Glance

CategoryDetail
Condition
Key MechanismsCombination of systemic therapies including chemotherapy, surgery, and radiotherapy, with emphasis on their roles in treatment outcomes.
Target Population
Care Setting

Key Highlights

  • Clarify the controversy regarding the necessity of supraclavicular lymph node dissection with specific study results.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • Regular imaging evaluations (e.g., CT, PET/CT) every 3-6 months for the first 2 years, then annually.

      Risks

        Patient & Prescribing Data

        326 female patients with sISLM treated between January 2010 to December 2021.

        Patients were divided into radiotherapy alone and surgery plus radiotherapy groups.

        Clinical Best Practices

        • Incorporate specific evidence from the study to support the necessity of multidisciplinary teams.

        References

        Original Source(s)

        Related Content